Skip to main content

Table 7 Children—antibodies (reciprocal dilution)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Categorical time

Number of individuals

Average time (days)

GMT (reciprocal dilution)

NV (0)

50

0

5

PV (30–45 days)

46

39 (30–57)

74

PV (1 year)

113

409 (243–549)

37

PV (2 years)

93

758 (558–909)

26

PV (4 years)

97

1529 (966–2064)

14

PV (7 years)

93

2562 (2379–2982)

10

PV (10 years)

111

3670 (3027–4239)

12